Keith Bowering

454 total citations
12 papers, 342 citations indexed

About

Keith Bowering is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Keith Bowering has authored 12 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in Keith Bowering's work include Diabetes Treatment and Management (10 papers), Diabetes Management and Research (7 papers) and Metabolism, Diabetes, and Cancer (5 papers). Keith Bowering is often cited by papers focused on Diabetes Treatment and Management (10 papers), Diabetes Management and Research (7 papers) and Metabolism, Diabetes, and Cancer (5 papers). Keith Bowering collaborates with scholars based in Canada, United States and United Kingdom. Keith Bowering's co-authors include Katja Rohwedder, S. Matthäei, Shamik Parikh, John M. Embil, Bruce W. Bode, Michael Sampson, John N. Harvey, Ditte‐Marie Bretler, Christopher Case and Jennifer Sugg and has published in prestigious journals such as Diabetes Care, Diabetic Medicine and Diabetes Obesity and Metabolism.

In The Last Decade

Keith Bowering

12 papers receiving 331 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keith Bowering Canada 6 336 143 130 42 31 12 342
M. Bogoev Denmark 6 405 1.2× 194 1.4× 49 0.4× 9 0.2× 130 4.2× 10 463
Marian Benroubi Greece 12 577 1.7× 107 0.7× 172 1.3× 58 1.4× 64 2.1× 17 603
Signe Frøssing Denmark 8 183 0.5× 42 0.3× 35 0.3× 80 1.9× 11 0.4× 9 354
Milivoj Piletič Denmark 6 435 1.3× 104 0.7× 256 2.0× 86 2.0× 25 0.8× 10 461
Oscar Minuchin Israel 5 177 0.5× 60 0.4× 31 0.2× 4 0.1× 40 1.3× 8 220
Helen Partridge United Kingdom 7 308 0.9× 200 1.4× 70 0.5× 21 0.5× 51 1.6× 16 333
Jamie Scism‐Bacon United States 9 583 1.7× 176 1.2× 155 1.2× 33 0.8× 86 2.8× 14 606
Sid McNulty United Kingdom 4 330 1.0× 89 0.6× 93 0.7× 12 0.3× 84 2.7× 13 361
Valérie Pilorget France 12 396 1.2× 124 0.9× 94 0.7× 31 0.7× 79 2.5× 27 428
Carlos Trescolí Spain 7 182 0.5× 52 0.4× 73 0.6× 13 0.3× 21 0.7× 8 186

Countries citing papers authored by Keith Bowering

Since Specialization
Citations

This map shows the geographic impact of Keith Bowering's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith Bowering with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith Bowering more than expected).

Fields of papers citing papers by Keith Bowering

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith Bowering. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith Bowering. The network helps show where Keith Bowering may publish in the future.

Co-authorship network of co-authors of Keith Bowering

This figure shows the co-authorship network connecting the top 25 collaborators of Keith Bowering. A scholar is included among the top collaborators of Keith Bowering based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith Bowering. Keith Bowering is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Peters, Anne L., et al.. (2019). Baseline nocturnal glucose change: A predictor of the treatment effect of bolus intensification in insulin‐treated type 2 diabetes. Diabetes Obesity and Metabolism. 21(7). 1752–1756. 1 indexed citations
2.
Bowering, Keith, Helena W. Rodbard, David Russell‐Jones, et al.. (2018). Investigating the Association Between Baseline Characteristics (HbA1c and Body Mass Index) and Clinical Outcomes of Fast-Acting Insulin Aspart in People with Diabetes: A Post Hoc Analysis. Diabetes Therapy. 10(1). 177–188. 3 indexed citations
3.
Embil, John M., Zaina Albalawi, Keith Bowering, & Elly Trepman. (2018). Foot Care. Canadian Journal of Diabetes. 42. S222–S227. 29 indexed citations
5.
Heller, Simon, et al.. (2018). The effect of basal–bolus therapy varies with baseline 1,5‐anhydroglucitol level in people with Type 2 diabetes: a post hoc analysis. Diabetic Medicine. 35(9). 1273–1278. 3 indexed citations
6.
Bowering, Keith, Christopher Case, John N. Harvey, et al.. (2017). Faster Aspart Versus Insulin Aspart as Part of a Basal-Bolus Regimen in Inadequately Controlled Type 2 Diabetes: The onset 2 Trial. Diabetes Care. 40(7). 951–957. 81 indexed citations
7.
Bowering, Keith, Christopher Case, John M. Harvey, et al.. (2016). Faster-Acting Insulin Aspart vs. Insulin Aspart in Basal-Bolus Therapy Improved Postprandial Glycemic Control in Uncontrolled T2D in the Onset® 2 Trial. Canadian Journal of Diabetes. 40(5). S57–S57. 4 indexed citations
9.
Matthäei, S., Keith Bowering, Katja Rohwedder, et al.. (2015). Durability and tolerability of dapagliflozin over 52 weeks as add‐on to metformin and sulphonylurea in type 2 diabetes. Diabetes Obesity and Metabolism. 17(11). 1075–1084. 56 indexed citations
10.
Bowering, Keith & John M. Embil. (2013). Foot Care. Canadian Journal of Diabetes. 37. S145–S149. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026